EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and genetic findings in 103 individuals in Norway with basal cell naevus syndrome

Karianne Haga Brandtzæg iD, Charlotte von der Lippe iD, Ingvild Kibsgaard Vestengen iD, Josephine Prener Holtan iD, Mona Irene Winge iD, Cecilie F Rustad iD, Tone Kristin Bergersen iD, Solrun Sigurdardottir iD, Wenche Sjursen iD, Petter Gjersvik iD, Kristin Halvorsen Hortemo iD

British Journal of Dermatology · 2026

DOI: 10.1093/bjd/ljaf413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2026. Verfasst von Karianne Haga Brandtzæg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Basal Cell Nevus Syndrome, Patched-1 Receptor, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Basal cell naevus syndrome (BCNS) is a rare autosomal dominant condition characterized by early onset and multiple basal cell carcinomas (BCCs), skeletal and ocular abnormalities, and extracutaneous tumours and cysts. In most cases, BCNS is caused by a pathogenic variant in the tumour suppressor gene PTCH1. Pathogenic variants in SUFU account for a minority of cases. No clear genotype–phenotype associations between different PTCH1 variants have been established.

Objectives

To identify all individuals with BCNS in Norway, characterize their clinical and genetic profiles, and investigate possible genotype–phenotype associations.

Methods

In this cross-sectional study, we approached all individuals with BCNS registered at the Department of Dermatology at Oslo University Hospital and two national resource centres for rare medical conditions. Dermatologists, dentists and geneticists across Norway were contacted in order to identify additional individuals with BCNS. Data were collected from structured interviews, whole-body physical examinations, electronic medical records, radiographic imaging and molecular genetic analyses.

Results

We identified 109 individuals with BCNS, indicating a national prevalence of BCNS of at least 1.9 per 100 000, of whom 103 agreed to be included. Clinical findings confirmed the considerable phenotypic variation in BCNS, including BCC in 61 individuals (median number of BCCs 48, range 1–1025), odontogenic keratocysts in 72 (median number of odontogenic keratocysts 5, range 1–30) and a wide spectrum of ocular and skeletal abnormalities in 43 and 98 individuals, respectively. This study is the first to report the prevalence estimates of autism (4%) and epilepsy (7%), as well as intracranial lesions associated with epilepsy, in BCNS. Genetic analyses identified a pathogenic or probable pathogenic PTCH1 variant in 93 individuals, while 5 individuals had variants of uncertain clinical significance. Twenty-one of the pathogenic PTCH1 variants were novel. None of the individuals with PTCH1 variants in exon 1, all belonging to the same family, exhibited BCCs, odontogenic keratocysts or palmoplantar pitting.

Conclusions

This study expands the number of pathogenic PTCH1 variants, elucidates important clinical aspects in BCNS and reveals novel insight to genotype–phenotype associations, providing new implications for management and follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell Nevus SyndromePatched-1 ReceptorSkin NeoplasmsHumansNorwayFemaleMaleCross-Sectional StudiesAdultMiddle AgedYoung AdultAdolescentChildAgedPhenotypeGenetic Association StudiesRepressor ProteinsBasal Cell CarcinomaMutation

Substanzen

Patched-1 ReceptorPTCH1 protein, humanSUFU protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Department of Dermatology, Oslo University Hospital, Oslo, Norway.
  • Department of Medical Genetics, Telemark Hospital, Skien, Norway.
  • Norwegian National Resource Center for Oral Health in Rare Disorders, Lovisenberg Diaconal Hospital, Oslo, Norway.
  • Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
  • Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway.

ORCID-Profile: Karianne Haga Brandtzæg, Charlotte von der Lippe, Ingvild Kibsgaard Vestengen, Josephine Prener Holtan, Mona Irene Winge, Cecilie F Rustad, Tone Kristin Bergersen, Solrun Sigurdardottir, Wenche Sjursen, Petter Gjersvik, Kristin Halvorsen Hortemo

Zitieren

APA

Brandtzæg, K. H., von der Lippe, C., Vestengen, I. K., Holtan, J. P., Winge, M. I., Rustad, C. F., Bergersen, T. K., Sigurdardottir, S., Sjursen, W., Gjersvik, P., & Hortemo, K. H. (2026). Clinical and genetic findings in 103 individuals in Norway with basal cell naevus syndrome. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljaf413

Vancouver

Brandtzæg KH, von der Lippe C, Vestengen IK, Holtan JP, Winge MI, Rustad CF, et al. Clinical and genetic findings in 103 individuals in Norway with basal cell naevus syndrome. British Journal of Dermatology. 2026. doi:10.1093/bjd/ljaf413

BibTeX
@article{Brandtzg2026,
  author = {Brandtzæg, Karianne Haga and von der Lippe, Charlotte and Vestengen, Ingvild Kibsgaard and Holtan, Josephine Prener and Winge, Mona Irene and Rustad, Cecilie F and Bergersen, Tone Kristin and Sigurdardottir, Solrun and Sjursen, Wenche and Gjersvik, Petter and Hortemo, Kristin Halvorsen},
  title = {Clinical and genetic findings in 103 individuals in Norway with basal cell naevus syndrome},
  journal = {British Journal of Dermatology},
  year = {2026},
  doi = {10.1093/bjd/ljaf413}
}
Kostenlos starten →